Larvol Delta - Fulgent-Data-at-ASCO-2023-Highlights-Progress-for-Its-Lead-Therapeutic-Oncology-Candidate-FID007-in-Various-Cancers

nanoencapsulated paclitaxel (FID-007) - ANP Technologies, Fulgent Genetics

https://www.businesswire.com/news/home/20230605005253/en/Fulgent-Data-at-ASCO-2023-Highlights-Progress-for-Its-Lead-Therapeutic-Oncology-Candidate-FID-007-in-Various-Cancers/

Jun 5, 2023

SHARE THIS

Print
Email
More sharing

Reddit

StumbleUpon

Delicious

Prev Next